Chemoinformaics analysis of L-(+)-Acetylhomoserine
Molecular Weight | 161.157 | nRot | 4 |
Heavy Atom Molecular Weight | 150.069 | nRig | 2 |
Exact Molecular Weight | 161.069 | nRing | 0 |
Solubility: LogS | -0.776 | nHRing | 0 |
Solubility: LogP | -3.075 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 21.6627 |
nHD | 1 | BPOL | 14.2353 |
QED | 0.535 |
Synth | 2.547 |
Natural Product Likeliness | 1.485 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.074 |
HIA | 0.307 |
CACO-2 | -5.872 |
MDCK | 0.00503726 |
BBB | 0.685 |
PPB | 0.121797 |
VDSS | 0.419 |
FU | 0.885143 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.037 |
CYP2c19-inh | 0.038 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.289 |
CYP2d6-inh | 0.089 |
CYP2d6-sub | 0.186 |
CYP3a4-inh | 0.018 |
CYP3a4-sub | 0.041 |
CL | 5.708 |
T12 | 0.637 |
hERG | 0.022 |
Ames | 0.031 |
ROA | 0.017 |
SkinSen | 0.186 |
Carcinogencity | 0.059 |
EI | 0.103 |
Respiratory | 0.07 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.927616 |